Company news
Lattice Biologics Ltd (OTC:LBLTF) news
Lattice Biologics Ltd news releases on 6ix. Latest, May 1, 2018: BCSC Revocation of Cease Trade Order
Press releases & updates
BCSC Revocation of Cease Trade Order
April 30, 2018
Lattice Biologics Ltd. Announces Management Cease Trade Order
January 30, 2018
Lattice Biologics Ltd. Announces Change in Director and Change in Status of Chief Operating Officer
December 22, 2017
Lattice Biologics Ltd. Reports Third Quarter 2017 Highlights
August 29, 2017
Notice of Lattice Biologics Ltd. Third Quarter 2017 Financial Results Conference Call
August 25, 2017
Lattice Biologics Ltd. Completes Debt to Equity Conversion and Issues Shares for Services
July 17, 2017
Lattice Biologics Ltd. Announces Change in Director and Chairman of Scientific Advisory Board
July 6, 2017
Lattice Biologics Ltd. Announces Move to Belgrade, Montana
June 26, 2017
Lattice Biologics Ltd. Announces Change to Location of Its Annual General and Special Meeting
June 20, 2017
Lattice Biologics Ltd. Announces Completion of Transaction to Reduce Royalty and Debt Obligations
June 13, 2017
Lattice Biologics Ltd. Receives Multi-Year American Association of Tissue Banks Re-Accreditation
June 1, 2017
Lattice Biologics Ltd. Appoints Chief Operating Officer
May 31, 2017
Lattice Biologics Ltd. Reports Second Quarter 2017 Highlights
May 30, 2017
Notice of Lattice Biologics Ltd. Second Quarter 2017 Financial Results Conference Call
May 17, 2017
Lattice Biologics Announces Completion of Private Placement
May 15, 2017
Lattice Biologics Announces Agreement to Successfully Reduce Royalty and Debt Obligations
April 26, 2017
Lattice Biologics Closes Fifth Tranche of Private Placement and Extends Funding Raise for an Additional 30 Days
April 6, 2017
Service Provider Loyalty Remains Strong as Lattice Biologics Issues Shares for Services and Announces Planned Debt-to-Equity Conversion
March 20, 2017
Lattice Biologics Extends Private Placement
March 7, 2017
Lattice Biologics Ltd. Reports First Quarter 2017 Highlights
March 1, 2017
Lattice Biologics Participates in $300 Million Public-Private Initiative, the Advanced Regenerative Manufacturing Institute (ARMI)
February 28, 2017
Lattice Biologics Closes Fourth Tranche of Private Placement Announced on January 19, 2017
February 28, 2017
Lattice Biologics Closes Third Tranche of Private Placement Announced on January 19, 2017
February 16, 2017
Notice of Lattice Biologics Ltd. First Quarter 2017 Financial Results Conference Call
February 14, 2017
Lattice Biologics Upgraded to OTCQB Venture Market
February 1, 2017
OTC Markets Group Welcomes Newly Verified OTCQB Companies – January 31
January 31, 2017
Lattice Biologics Issues Common Shares
January 5, 2017